ALC:NYSE
Alcon AG
US$ ७०.१७
arrow_downward
-०.६९%(-०.४९) 1D
US$ ७०.१७
०.००% (०.००)
bedtimeAfter hours
Closed: अक्टोबर २३, १६:००:०५ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
US$ ७०.१६
High
US$ ७०.४६
Low
US$ ६९.५४
Mkt. cap
२८.८१ अरब
Avg. vol.
१७.६७ लाख
Volume
२५.९२ लाख
52-wk high
US$ ८७.६४
52-wk low
US$ ६१.८४
Beta
०.८८
Shares outstanding
४८.३४ करोड
No. of employees
२५ हजार
Open
US$ ७०.१६
High
US$ ७०.४६
Low
US$ ६९.५४
Mkt. cap
२८.८१ अरब
Avg. vol.
१७.६७ लाख
Volume
२५.९२ लाख
52-wk high
US$ ८७.६४
52-wk low
US$ ६१.८४
Beta
०.८८
Shares outstanding
४८.३४ करोड
No. of employees
२५ हजार
News stories
From web sources and news partners
GuruFocus
·
२२ घण्टा पहिले
Alcon Inc (ALC) Shares Surge 4.8% -- What GF Score of 74 Tells I
Fierce Pharma
·
२ दिन पहिले
Alcon ponies up $550M for Neurotech, bagging approved cell therapy implant Encelto
Yahoo Finance
·
३ दिन पहिले
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees२५ हजार
Founded१९४५
Headquartersजेनेभा, Geneva, स्विट्जरल्यान्ड
Sector-
Websitealcon.com